Stephanie A. Stein, MD

Peer-Reviewed Journal Articles


Stein SA, Wartofsky L. Screening for thyroid disease: defining high-risk populations. Exp Rev Endocrinol Metab. 2010;(5): 663-71.


Lamos EM, Stein SA, Davis SN. Combination glibenclamide-metformin HCl for the treatment of type 2 diabetes. Expert Opinion on Pharmacother. 2012;(13):2545-54.


Stein SA, Lamos EM, Davis SN. A review of the efficacy and safety of oral hypoglycemic agents. Expert Opin Drug Saf. 2013;(12):153-75.


Stein SA, Wartofsky L. Primary thyroid lymphoma: a clinical review. J Clin Endocrinol Metab. 2013; (98): 3131-3138.


Lamos EM, Stein SA, Davis SN. Sulfonylureas and meglitinides: historical and contemporary issues. Panminerva Med. 2013; (55): 239-51.


Konig M, Lamos EM, Stein SA, Davis SN. An insight into the recent diabetes trials: what is the best approach to prevent macrovascular and microvascular complications? Curr Diabetes Rev. 2013; (9): 371-81.


Stein SA, Lamos EM, Davis SN. Vildagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of type 2 diabetes. Expert Opin Drug Metab Toxicol. 2014; (10): 599-608


Stein SA, Maloney KM, Pollin TI.  Genetic counseling for diabetes mellitus. Curr Genet Med Rep. 2014; (2): 56-67


Mohtasebi Y, Munir KM, Stein SA. A case of giant prolactinoma, initially misdiagnosed as sinonasal neuroendocrine carcinoma.  Interdisciplinary neurosurgery. 2015; (2): 126-28.



Book Chapters

Stein SA, Lamos E, Quartuccio M, Chandraskaran S, Ionica N, Steinle N. Food Intake and Preference. In: Diet Quality: An Evidence Based Approach, Volume 1. Humana Press, New York, NY. 2013


Stein SA, Kant R, Malek R, Shuldiner AR. The Genetic Architecture of Diabetes in Pregnancy.  In: The Diabetes in Pregnancy Dilemma, 2nd edition. PMPH–USA, Shelton, CT.